Literature DB >> 11435804

Restless legs syndrome: a review of clinical and pathophysiologic features.

R P Allen1, C J Earley.   

Abstract

Restless legs syndrome (RLS), although long ignored and still much underdiagnosed, disrupts the life and sleep considerably of those who have it. Recent clinical and basic research provides for better definition and pathophysiologic understanding of the disorder. The body of knowledge about this disorder has been expanding rapidly during the past decade and it has altered our concepts of this disorder. This review of RLS covers history, diagnosis, morbidity of sleep disturbance, relation to periodic limb movements in both sleep and waking, secondary causes, severity assessment methods, phenotypes for possible genetic patterns, epidemiology, pathophysiology, and medical treatment considerations. The emphasis on pathophysiology includes consideration of central nervous system localization, neurotransmitter and other systems involved, and the role of iron metabolism. Studies to date support the authors' recently advanced iron-dopamine model of RLS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435804     DOI: 10.1097/00004691-200103000-00004

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  66 in total

1.  Restless legs syndrome due to aripiprazole.

Authors:  Juan Bolaños-Vergaray; Juan Carlos Obaya; Rafael Gonzalez; Cristina Echeverri; Pilar Piquer
Journal:  Eur J Clin Pharmacol       Date:  2010-11-21       Impact factor: 2.953

2.  The burden of restless legs syndrome: an assessment of work productivity, sleep, psychological distress, and health status among diagnosed and undiagnosed individuals in an internet-based panel.

Authors:  Sheri Fehnel; Laurie Zografos; Tammy Curtice; Hemal Shah; Lori McLeod
Journal:  Patient       Date:  2008-07-01       Impact factor: 3.883

3.  Treatment of restless legs syndrome with subcutaneous apomorphine in a patient with short bowel syndrome.

Authors:  T Tings; G Stiens; W Paulus; C Trenkwalder; S Happe
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

Review 4.  Management of restless legs syndrome in patients on dialysis.

Authors:  Miklos Z Molnar; Marta Novak; Istvan Mucsi
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 5.  Prevalence of restless legs syndrome in North American and Western European populations: a systematic review.

Authors:  Kim E Innes; Terry Kit Selfe; Parul Agarwal
Journal:  Sleep Med       Date:  2011-07-12       Impact factor: 3.492

6.  Evaluating daytime alertness in individuals with Restless Legs Syndrome (RLS) compared to sleep restricted controls.

Authors:  Charlene Gamaldo; Amy R Benbrook; Richard P Allen; Oluwamurewa Oguntimein; Christopher J Earley
Journal:  Sleep Med       Date:  2008-01-28       Impact factor: 3.492

7.  Restless legs syndrome: a unique case and essentials of diagnosis and treatment.

Authors:  Pinky Agarwal; Alida Griffith
Journal:  Medscape J Med       Date:  2008-12-31

Review 8.  Ropinirole: for the treatment of restless legs syndrome.

Authors:  Susan M Cheer; Lynne M Bang; Gillian M Keating
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

9.  Restless legs syndrome in patients with systemic sclerosis. Prevalence and possible causes.

Authors:  P Ostojic; T Jovic; B Stojic
Journal:  Z Rheumatol       Date:  2013-08       Impact factor: 1.372

10.  Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p.

Authors:  Shenghan Chen; William G Ondo; Shaoqi Rao; Lin Li; Qiuyun Chen; Qing Wang
Journal:  Am J Hum Genet       Date:  2004-04-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.